Annual Jockey Club Round Table tackles model rule on AASThe 2009 Jockey Club Roundtable was recently held at the Gideon Putnam Hotel in Saratoga Springs, New York. It was held last August 23, 2009.

The discussion was geared towards medication reform and the RCI Model Rule on androgenic-anabolic steroids.

The RCI Model Rule on AAS calls for all North American racing authorities to implement the model rule no later than December 31, 2008. Stuart Janney, chairman of The Jockey Club’s Thoroughbred Safety Committee, believes that the rule effectively eliminated the use of anabolic steroids in training and racing of Thoroughbreds.

Short-term benefits of implementing the RCI model rule are pretty much obvious but the most essential part is the long-term benefits. Horses will be in a healthier state in their post-racing days, and owners will be more confident knowing that their horses accomplished something without the use of steroids.

The RCI Model Rule on Androgenic Anabolic Steroids states that no AAS shall be permitted in test samples collected from racing horses except for traces or residues of stanozolol, nandrolone, boldenone and testosterone at concentrations less than the indicated thresholds.

All other AAS are prohibited in racing horses. In cases where AAS was administered to aid recovery from injury, the horse must be placed on the vet’s list.